Type 2 Diabetes Clinical Trials in Philadelphia, Pennsylvania

4 studies are recruiting for type 2 diabetes in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

    This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive eit…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Northeast Endocrine Metabolic Associates, Philadelphia, Pennsylvania
    Locations
    303 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07564414 on ClinicalTrials.gov

  2. A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.

    Stage
    Phase 3
    Ages
    10 to 17
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Locations
    51 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06739122 on ClinicalTrials.gov

  3. The GRoceries Aimed at Increasing Nutrition Study

    Only 2% of Americans meet the recommended levels of whole grain consumption, despite its association with reduced risk of type 2 diabetes. This study aims to assess if consumers with prediabetes or type 2 diabetes can be encouraged to switch from buying refined grain products to whole grain product…

    Stage
    Not phased
    Ages
    45 to 70
    Site
    University of Pennsylvania, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania

    See if you can join NCT07167004 on ClinicalTrials.gov

  4. Sleep and Glycemic Control in Type 2 Diabetes Adolescents

    The primary objective is to determine the cross-sectional relationship between sleep duration (as measured by 14 days of actigraphy) and glycemic control in an adolescent Type 2 Diabetes (T2DM) cohort (age 12-20y, n=67). A secondary objective is to determine if a loss-framed incentive for achieving…

    Stage
    Not phased
    Ages
    12 to 20
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Run by
    Children's Hospital of Philadelphia

    See if you can join NCT04213547 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.